Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh $54.75

down -0.30


24/7/2014 12:35 PM  |  NYSE : TEVA  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get TEVA Trend Analysis - it has outperformed the S&P 500 by 16%

Partner Headlines

  1. George Soros Reveals His Largest Stake

    GuruFocus
  2. Sofinnova Ventures Closes $500M Fund

    FoxBusiness
  3. Israel's Market Appears Unfazed By Rising Conflict

    IBD
  4. George Soros Keeps Buying TEVA, EQT, YPF, EGN, CZR And Keeps Selling GOOGL, ...

    GuruFocus
  5. UPDATE: Teva Announces FDA Acceptance of NDA For Inhaler

    Benzinga
  6. 4 Top Performing Health Care Stocks With More Potential Upside

    Benzinga
  7. Salix, Akorn, Regeneron Lead Drug Stock Rally

    IBD
  8. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  9. Diamond Hill Capital Comments on Teva Pharmaceutical Industries Ltd

    GuruFocus
  10. Diamond Hill Select Fund Commentary - First Quarter 2014

    GuruFocus
  11. Teva Pharmaceutical

    IBD
  12. Generic-Drug Makers Climb Ranks; Several In Buy Range

    IBD
  13. Teva Turmoil: Shares Up, Board Trimmed, CEO To Retire

    Benzinga
  14. Wells Fargo Initiates Coverage On The Pharmaceutical Space

    Benzinga
  15. Top Guru Held Asian Companies of the First Quarter

    GuruFocus
  16. Teva to buy Labrys Biologics

    IBD
  17. Chicago sues painkiller firms

    IBD
  18. Benzinga's M&A Chatter for Tuesday June 3, 2014

    Benzinga
  19. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  20. Richard Snow's Top Five Highlight Finance and Healthcare Sectors

    GuruFocus
  21. Benzinga's M&A Chatter for Wednesday May 7, 2014

    Benzinga
  22. ETF Outlook For Tuesday May 6, 2014 (EUFN, ITA, EIS, UAE)

    Benzinga
  23. Wrong Marketing Lesson by Big Pharma

    GuruFocus
  24. Sterne Agee Sees Mixed Factors For Teva Pharmaceutical Industries Ltd.

    Benzinga
  25. Teva EPS tops; rivals seen?

    IBD
  26. Market Wrap For May 1: Markets Mixed To Start The New Month

    Benzinga
  27. Earnings Scheduled For May 1, 2014

    Benzinga
  28. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  29. Actavis Reporting Q1 Earnings Amid Merger Frenzy

    IBD
  30. US Stock Futures Up Ahead Of Earnings, Consumer Confidence Data

    Benzinga
  31. Morning Market Losers

    Benzinga
  32. Benzinga's Top #PreMarket Losers

    Benzinga
  33. UPDATE: Teva, Oncogenex Offer Top-Line Survival Results of Phase III SYNERGY ...

    Benzinga
  34. Nasdaq Could Be in for a Bounce

    FoxBusiness
  35. Actavis got a Pfizer

    IBD
  36. Teva Settles Patent Litigation with Pfizer on Celebrex; Has Received Tenative ...

    Benzinga
  37. Sterne Agee Sees Teva Pharmaceutical Outperformance Continuing

    Benzinga
  38. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  39. Teva Announces First Approval and Launch of Generic Lovaza® Capsules in ...

    Benzinga
  40. Market Wrap For April 7: Bears In Complete Control As Markets Get Hammered ...

    Benzinga
  41. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
  42. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy

    Benzinga
  43. Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma

    Benzinga
  44. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  45. Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says

    Benzinga
  46. UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

    Benzinga
  47. Forest Laboratories' Recovery

    GuruFocus
  48. Should You Buy Actavis?

    GuruFocus
  49. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  50. UPDATE: JP Morgan Upgrades Teva Pharmaceuticals

    Benzinga
Trading Center